1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products
1. The subject of the contract is the supply of materials for pharmaceutical products, according to 66 tasks, in accordance with the quantities and requirements contained in Annex 3 to this specification "Assortment and price form",
(a) partial tenders may be submitted for specific tasks;
(b) a partial selection of tenders shall be reserved, where part is a particular task;
(c) tenders which do not contain the full scope of the subject matter of the contract as defined in Annex 3 to the specifications for individual tasks shall be rejected;
(d) The contractor may submit tenders for one, several or all tasks.
2. Additional conditions concerning the subject of the contract:
a) the unit price of a medicine included in the list of reimbursed drugs may not be higher than it results from the provision of Article 9 paragraph 2 of the Act of 12.05.2011 on the reimbursement of medicines, foodstuffs for particular nutritional uses and medical devices,
b) The Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ),
c) All proper names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties as well as the requirements assumed for the subject of the contract. In this case, the Ordering Party allows the use of equivalent solutions, provided that it meets all the requirements of the Ordering Party.
d) Quality requirements for medicinal products are specified in the Act of 6 September 2001 - Pharmaceutical Law (Journal of Laws of 2021, item 1977, as amended), which in Art. Article 1(1)(1) provides that it lays down m.in the principles and procedures for the authorisation of medicinal products, taking into account, in particular, the requirements relating to quality, efficacy and safety.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979 with późn.zm) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the proceedings in question, the quality standard of medicinal products has been defined by the Ordering Party by specifying in the description of the subject of the contract, which includes, m.in: composition, form and route of administration as well as a unit of measurement.
3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products